- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Insight 779 results
Client Alert
February 26, 2020
Capital Gains Tax (CGT) payable by non-UK resident investors on direct and indirect disposals of UK commercial real estate
Client Alert
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
Client Alert
February 24, 2020
Emerging Regulation, Enforcement, and Litigation Involving Ethylene Oxide, a Critical Substance for Sterilizing Medical Products and Devices
Client Alert
February 24, 2020
FDA FY 2021 Budget Foretells Medical Device Cybersecurity Reform
Client Alert
February 21, 2020
Big Three Investors Announce 2020 Priorities
Client Alert
February 18, 2020
Leave means…business as usual? The Post-Brexit Implications for Dispute Resolution in the Middle East
Client Alert
February 14, 2020
CFIUS Finalizes Rules Reforming Foreign Investment Reviews
Client Alert
February 11, 2020
The UK Begins Consultations to Inform "The UK Global Tariff", its New WTO Tariff Schedule
Client Alert
February 10, 2020
Covered Funds May Cover Less
Client Alert
February 7, 2020
FDA Releases Draft Guidance on Promotion of Biological Reference and Biosimilar Products
Client Alert
February 5, 2020
Freedom of Contract Cited as the Reason for Texas Supreme Court's Affirmation of Court of Appeals Judgment in ETP v. Enterprise
Client Alert
February 4, 2020
Federal Reserve Reinterprets Control